This study identifies 4 predictors of COVID-19 mortality, inflammatory markers (CRP), coagulation function (PT-INR), and Lactate at admission are risk factors for prognosis, patients with Ambavizumab-romivizumab therapy have a better prognosis. The gene discussed is CRP; the disease is COVID-19.